According to GlobalData, ICON is one of 160 product lines sold in the US respiratory disease tests market; these product lines are sold by 75 different manufacturers. The average selling price for ICON decreased in hospitals, increased in health systems, and decreased outside of hospital facilities in 2022. The price of the ICON device can be viewed in GlobalData’s micro pricing report and can be retrieved according to purchase date, facility type, bed size, and geographical region. Buy the report here.

Smarter leaders trust GlobalData

The selling price or list price of a medical device is driven by numerous factors, such as therapy area and complexity of procedure, level of reimbursement, development costs, the number of competing manufacturers, product life cycle, and whether there have been any recent new technology or product launches.

In addition, the final selling pricing of medical devices is also impacted by the discounting policy of the manufacturer. Companies such as Beckman Coulter apply discounts for their devices based on their internal business strategy, inventory control, and monthly or quarterly sales targets. In addition, sale location can also affect the final selling price of a device, both in terms of geographical region and facility type. Prices for the same medical device often vary in hospitals and health systems versus outside of hospital facilities, for example if high volume healthcare institutions can negotiate discounts or rebates based on large purchase sizes.

Beckman Coulter overview

Beckman Coulter Inc (Beckman), a subsidiary of Danaher Corp, is a manufacturer of biomedical testing instrument systems. It develops, manufactures and markets biomedical laboratory instruments, software and other things that simplify and automate complex biomedical tests. Its comprehensive diagnostic tests, instruments and business management services help healthcare professionals in hospitals, laboratories and other critical care settings across the world to assess, diagnose and monitor conditions ranging from cardiac diseases to blood disorders, metabolic functions, infectious diseases, and cancer, among others. The company also provides scientific solutions for laboratory customers such as universities, biotechnology and pharmaceutical companies, government, hospitals, and commercial laboratories. It operates across the US, Europe, Canada, and Asia with clinical and research systems operating in laboratories around the world. Beckman is headquartered in Brea, California, the US.

For a complete picture of ICON, Respiratory Disease Tests pricing in the US, buy the report here.

Data Insights


The gold standard of business intelligence.

Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.


GlobalData, the leading provider of industry intelligence, provided the underlying data, research, and analysis used to produce this article.

GlobalData’s Medical Intelligence Center Market Models are the gold standard of medical device market valuation, company share estimation and market trend forecasting. GlobalData uses a patient-based forecast model or installed base methodology to determine the market size for therapeutic indications and capital equipment expenditures. Estimates are based on a number of sources, including primary research—KOL and industry contact interviews—and secondary research, such as company reports, press releases, published articles, proprietary databases, and general news media.